{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:43:22Z","timestamp":1793825002612,"version":"4.6.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["201920-191620023107"],"award-info":[{"award-number":["201920-191620023107"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Science and Technology-The Science and Engineering Research Board\u2013Extra Mural Research","award":["EMR\/2017\/005381"],"award-info":[{"award-number":["EMR\/2017\/005381"]}]},{"name":"Department of Biotechnology \u2013 Bioinformatics facility","award":["BT\/BI\/25\/063\/2012"],"award-info":[{"award-number":["BT\/BI\/25\/063\/2012"]}]},{"name":"Department of Science and Technology","award":["SR\/FST\/LSI 616\/2014"],"award-info":[{"award-number":["SR\/FST\/LSI 616\/2014"]}]},{"name":"University Grants Commission-Special Assistance Program","award":["UGC-SAP III: F.3-19 \/2018\/DRS-III(SAP- II)"],"award-info":[{"award-number":["UGC-SAP III: F.3-19 \/2018\/DRS-III(SAP- II)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disease characterized by the formation of amyloid plaques implicated in neuronal death. Genetics, age, and sex are the risk factors attributed to AD. Though omics studies have helped to identify pathways associated with AD, an integrated systems analysis with the available data could help to understand mechanisms, potential biomarkers, and therapeutic targets. Analysis of transcriptomic data sets from the GEO database, and proteomic and metabolomic data sets from literature was performed to identify deregulated pathways and commonality analysis identified overlapping pathways among the data sets. The deregulated pathways included those of neurotransmitter synapses, oxidative stress, inflammation, vitamins, complement, and coagulation pathways. Cell type analysis of GEO data sets showed microglia, endothelial, myeloid, and lymphoid cells are affected. Microglia are associated with inflammation and pruning of synapses with implications for memory and cognition. Analysis of the protein-cofactor network of B\n                    <jats:sub>2<\/jats:sub>\n                    , B\n                    <jats:sub>6,<\/jats:sub>\n                    and pantothenate shows metabolic pathways modulated by these vitamins which overlap with the deregulated pathways from the multi-omics analysis. Overall, the integrated analysis identified the molecular signature associated with AD. Treatment with anti-oxidants, B\n                    <jats:sub>2<\/jats:sub>\n                    , B\n                    <jats:sub>6<\/jats:sub>\n                    , and pantothenate in genetically susceptible individuals in the pre-symptomatic stage might help in better management of the disease.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-30892-6","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T06:22:08Z","timestamp":1678083728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Integrated multi-omics analysis of Alzheimer\u2019s disease shows molecular signatures associated with disease progression and potential therapeutic targets"],"prefix":"10.1038","volume":"13","author":[{"given":"Pradeep","family":"Kodam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sai Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Sanwid","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venketesh","family":"Sivaramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Vadrevu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"30892_CR1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1221","author":"MP Murphy","year":"2010","unstructured":"Murphy, M. P. & Levine, H. Alzheimer\u2019s disease and the amyloid-\u03b2 peptide. J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.3233\/JAD-2010-1221 (2010).","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"3","key":"30892_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.celrep.2019.03.099","volume":"176","author":"SR McCurdy","year":"2017","unstructured":"McCurdy, S. R. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Physiol Behav. 176(3), 139\u2013148. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.099 (2017).","journal-title":"Physiol Behav."},{"key":"30892_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031039","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga, C. et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0031039 (2012).","journal-title":"PLoS ONE"},{"key":"30892_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-01798-0","author":"JI V\u00e9lez","year":"2020","unstructured":"V\u00e9lez, J. I. et al. Familial Alzheimer\u2019s disease and recessive modifiers. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-019-01798-0 (2020).","journal-title":"Mol Neurobiol."},{"issue":"10","key":"30892_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1101\/cshperspect.a006296","volume":"2","author":"RE Tanzi","year":"2012","unstructured":"Tanzi, R. E. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2(10), 55. https:\/\/doi.org\/10.1101\/cshperspect.a006296 (2012).","journal-title":"Cold Spring Harb Perspect Med."},{"key":"30892_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.263","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein e and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/nrneurol.2012.263 (2013).","journal-title":"Nat Rev Neurol."},{"key":"30892_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2620","author":"G Bu","year":"2009","unstructured":"Bu, G. Apolipoprotein e and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/nrn2620 (2009).","journal-title":"Nat Rev Neurosci."},{"issue":"7937","key":"30892_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard, J. W. et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611(7937), 769\u2013779. https:\/\/doi.org\/10.1038\/s41586-022-05439-w (2022).","journal-title":"Nature"},{"key":"30892_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.631827","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Interplay between microglia and Alzheimer\u2019s disease\u2014focus on the most relevant risks: APOE genotype, sex and age. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2021.631827 (2021).","journal-title":"Front Aging Neurosci."},{"key":"30892_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00913-5","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol. https:\/\/doi.org\/10.1038\/s41590-021-00913-5 (2021).","journal-title":"Nat Immunol."},{"issue":"7","key":"30892_CR11","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1073\/pnas.052587399","volume":"99","author":"MN Rossor","year":"2002","unstructured":"Rossor, M. N., Scahill, R. I., Fox, N. C., Schott, J. M. & Stevens, J. M. Mapping the evolution of regional atrophy in Alzheimer\u2019s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 99(7), 4703\u20134707 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"30892_CR12","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-7-3","author":"RR Tampi","year":"2021","unstructured":"Tampi, R. R., Forester, B. P. & Agronin, M. Aducanumab: evidence from clinical trial data and controversies. Drugs Context https:\/\/doi.org\/10.7573\/dic.2021-7-3 (2021).","journal-title":"Drugs Context"},{"key":"30892_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00813-8","author":"CJ Swanson","year":"2021","unstructured":"Swanson, C. J. et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alzheimer\u2019s Res Ther. https:\/\/doi.org\/10.1186\/s13195-021-00813-8 (2021).","journal-title":"Alzheimer\u2019s Res Ther."},{"issue":"February","key":"30892_CR14","doi-asserted-by":"publisher","first-page":"100227","DOI":"10.1016\/j.bbih.2021.100227","volume":"13","author":"QS Li","year":"2021","unstructured":"Li, Q. S. & De Muynck, L. Differentially expressed genes in Alzheimer\u2019s disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1. Brain Behav Immun - Heal. 13(February), 100227. https:\/\/doi.org\/10.1016\/j.bbih.2021.100227 (2021).","journal-title":"Brain Behav Immun - Heal."},{"key":"30892_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00376-6","author":"W Wang","year":"2020","unstructured":"Wang, W., Zhao, F., Ma, X., Perry, G. & Zhu, X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-020-00376-6 (2020).","journal-title":"Mol Neurodegener."},{"key":"30892_CR16","doi-asserted-by":"publisher","unstructured":"Thota, S. M. et al. Multimodal imaging and visual evoked potentials reveal key structural and functional features that distinguish symptomatic from Presymptomatic Huntington\u2019s disease brain, Neurol India https:\/\/doi.org\/10.4103\/0028-3886.329528 (2021).","DOI":"10.4103\/0028-3886.329528"},{"key":"30892_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006213","author":"KA Johnson","year":"2012","unstructured":"Johnson, K. A., Fox, N. C., Sperling, R. A. & Klunk, W. E. Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a006213 (2012).","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"June","key":"30892_CR18","doi-asserted-by":"publisher","first-page":"119985","DOI":"10.1016\/j.lfs.2021.119985","volume":"285","author":"S Mani","year":"2021","unstructured":"Mani, S. et al. Mitochondrial defects: an emerging theranostic avenue towards Alzheimer\u2019s associated dysregulations. Life Sci. 285(June), 119985. https:\/\/doi.org\/10.1016\/j.lfs.2021.119985 (2021).","journal-title":"Life Sci."},{"key":"30892_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101503","author":"T Song","year":"2021","unstructured":"Song, T. et al. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2021.101503 (2021).","journal-title":"Ageing Res Rev."},{"key":"30892_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117253","author":"V Bhatia","year":"2021","unstructured":"Bhatia, V. & Sharma, S. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer\u2019s disease. J Neurol Sci. Published online https:\/\/doi.org\/10.1016\/j.jns.2020.117253 (2021).","journal-title":"J Neurol Sci. Published online"},{"key":"30892_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903563106","author":"J Yao","year":"2009","unstructured":"Yao, J. et al. Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.0903563106 (2009).","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"30892_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","volume":"21","author":"I Maurer","year":"2000","unstructured":"Maurer, I., Zierz, S. & M\u00f6ller, H. J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging. 21(3), 455\u2013462. https:\/\/doi.org\/10.1016\/S0197-4580(00)00112-3 (2000).","journal-title":"Neurobiol Aging."},{"key":"30892_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02152-8","author":"TG Demarest","year":"2020","unstructured":"Demarest, T. G. et al. Biological sex and DNA repair deficiency drive Alzheimer\u2019s disease via systemic metabolic remodeling and brain mitochondrial dysfunction. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-020-02152-8 (2020).","journal-title":"Acta Neuropathol."},{"key":"30892_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.662242","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Alshakhshir, N. & Zhao, L. Glycolytic metabolism, brain resilience, and Alzheimer\u2019s disease. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2021.662242 (2021).","journal-title":"Front Neurosci."},{"key":"30892_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06637-2","author":"ER Hascup","year":"2022","unstructured":"Hascup, E. R., Sime, L. N., Peck, M. R. & Hascup, K. N. Amyloid-\u03b242 stimulated hippocampal lactate release is coupled to glutamate uptake. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-06637-2 (2022).","journal-title":"Sci Rep."},{"key":"30892_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-013-0026-y","author":"L Mosconi","year":"2013","unstructured":"Mosconi, L. Glucose metabolism in normal aging and Alzheimer\u2019s disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging. https:\/\/doi.org\/10.1007\/s40336-013-0026-y (2013).","journal-title":"Clin Transl Imaging."},{"key":"30892_CR27","doi-asserted-by":"publisher","unstructured":"Mosconi L, Pupi A, De Leon MJ. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. In: Annals of the New York Academy of Sciences. 2008. doi:https:\/\/doi.org\/10.1196\/annals.1427.007","DOI":"10.1196\/annals.1427.007"},{"key":"30892_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00427","author":"RE Gonz\u00e1lez-Reyes","year":"2017","unstructured":"Gonz\u00e1lez-Reyes, R. E., Nava-Mesa, M. O., Vargas-S\u00e1nchez, K., Ariza-Salamanca, D. & Mora-Mu\u00f1oz, L. Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2017.00427 (2017).","journal-title":"Front Mol Neurosci."},{"key":"30892_CR29","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2027-14.2014","author":"ME Murray","year":"2014","unstructured":"Murray, M. E. et al. Early Alzheimer\u2019s disease neuropathology detected by proton MR spectroscopy. J Neurosci. Published online https:\/\/doi.org\/10.1523\/JNEUROSCI.2027-14.2014 (2014).","journal-title":"J Neurosci. Published online"},{"key":"30892_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010129","author":"AA Lauer","year":"2022","unstructured":"Lauer, A. A. et al. Mechanistic link between vitamin B12 and Alzheimer\u2019s disease. Biomolecules https:\/\/doi.org\/10.3390\/biom12010129 (2022).","journal-title":"Biomolecules"},{"issue":"1","key":"30892_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.13207","volume":"26","author":"CA Calder\u00f3n-Ospina","year":"2020","unstructured":"Calder\u00f3n-Ospina, C. A. & Nava-Mesa, M. O. B Vitamins in the nervous system: current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther. 26(1), 5\u201313. https:\/\/doi.org\/10.1111\/cns.13207 (2020).","journal-title":"CNS Neurosci Ther."},{"issue":"March","key":"30892_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2021.659402","volume":"13","author":"BD Paul","year":"2021","unstructured":"Paul, B. D. Neuroprotective roles of the reverse transsulfuration pathway in Alzheimer\u2019s disease. Front Aging Neurosci. 13(March), 1\u20139. https:\/\/doi.org\/10.3389\/fnagi.2021.659402 (2021).","journal-title":"Front Aging Neurosci."},{"issue":"11","key":"30892_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12113458","volume":"12","author":"A Mielech","year":"2020","unstructured":"Mielech, A., Pu\u015bcion-Jakubik, A., Markiewicz-\u017cukowska, R. & Socha, K. Vitamins in alzheimer\u2019s disease: review of the latest reports. Nutrients 12(11), 1\u201315. https:\/\/doi.org\/10.3390\/nu12113458 (2020).","journal-title":"Nutrients"},{"key":"30892_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101284","author":"SN Rai","year":"2021","unstructured":"Rai, S. N. et al. The role of vitamins in neurodegenerative disease: an update. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9101284 (2021).","journal-title":"Biomedicines."},{"key":"30892_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/75.4.616","author":"BN Ames","year":"2002","unstructured":"Ames, B. N., Elson-Schwab, I. & Silver, E. A. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. Am J Clin Nutr. https:\/\/doi.org\/10.1093\/ajcn\/75.4.616 (2002).","journal-title":"Am J Clin Nutr."},{"issue":"June","key":"30892_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2022.893159","volume":"14","author":"C Sang","year":"2022","unstructured":"Sang, C. et al. Coenzyme A-dependent tricarboxylic acid cycle enzymes are decreased in Alzheimer\u2019s disease consistent with cerebral pantothenate deficiency. Front Aging Neurosci. 14(June), 1\u201313. https:\/\/doi.org\/10.3389\/fnagi.2022.893159 (2022).","journal-title":"Front Aging Neurosci."},{"issue":"6","key":"30892_CR37","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.4314\/tjpr.v17i6.10","volume":"17","author":"R Zhao","year":"2018","unstructured":"Zhao, R., Wang, H., Qiao, C. & Zhao, K. Vitamin B2 blocks development of Alzheimer\u2019s disease in APP\/PS1 transgenic mice via anti-oxidative mechanism. Trop J Pharm Res. 17(6), 1049\u20131054. https:\/\/doi.org\/10.4314\/tjpr.v17i6.10 (2018).","journal-title":"Trop J Pharm Res."},{"issue":"23","key":"30892_CR38","doi-asserted-by":"publisher","first-page":"9523","DOI":"10.1073\/pnas.1301816110","volume":"110","author":"G Douaud","year":"2013","unstructured":"Douaud, G. et al. Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci USA. 110(23), 9523\u20139528. https:\/\/doi.org\/10.1073\/pnas.1301816110 (2013).","journal-title":"Proc Natl Acad Sci USA."},{"key":"30892_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/nu8020068","author":"DO Kennedy","year":"2016","unstructured":"Kennedy, D. O. B vitamins and the brain: mechanisms, dose and efficacy: a review. Nutrients https:\/\/doi.org\/10.3390\/nu8020068 (2016).","journal-title":"Nutrients"},{"key":"30892_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.530219","author":"X Yan","year":"2020","unstructured":"Yan, X., Hu, Y., Wang, B., Wang, S. & Zhang, X. Metabolic dysregulation contributes to the progression of Alzheimer\u2019s disease. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.530219 (2020).","journal-title":"Front Neurosci."},{"key":"30892_CR41","doi-asserted-by":"publisher","DOI":"10.2174\/1570159x16666180926123722","author":"C Pe\u00f1a-Bautista","year":"2018","unstructured":"Pe\u00f1a-Bautista, C., Baquero, M., Vento, M. & Ch\u00e1fer-Peric\u00e1s, C. Omics-based biomarkers for the early Alzheimer disease diagnosis and reliable therapeutic targets development. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/1570159x16666180926123722 (2018).","journal-title":"Curr Neuropharmacol."},{"key":"30892_CR42","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150398","author":"M Magistri","year":"2015","unstructured":"Magistri, M., Velmeshev, D., Makhmutova, M. & Faghihi, M. A. Transcriptomics profiling of Alzheimer\u2019s disease reveal neurovascular defects, altered amyloid-\u03b2 homeostasis, and deregulated expression of long noncoding RNAs. J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.3233\/JAD-150398 (2015).","journal-title":"J Alzheimer\u2019s Dis."},{"key":"30892_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01273","author":"JA Santiago","year":"2019","unstructured":"Santiago, J. A., Bottero, V. & Potashkin, J. A. Transcriptomic and network analysis highlight the association of diabetes at different stages of Alzheimer\u2019s disease. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2019.01273 (2019).","journal-title":"Front Neurosci."},{"key":"30892_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1195-2","author":"H Mathys","year":"2019","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature https:\/\/doi.org\/10.1038\/s41586-019-1195-2 (2019).","journal-title":"Nature"},{"key":"30892_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9120301","author":"S Srivastava","year":"2019","unstructured":"Srivastava, S. Emerging insights into the metabolic alterations in aging using metabolomics. Metabolites https:\/\/doi.org\/10.3390\/metabo9120301 (2019).","journal-title":"Metabolites"},{"key":"30892_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(96)00033-0","author":"M Ogawa","year":"1996","unstructured":"Ogawa, M., Fukuyama, H., Ouchi, Y., Yamauchi, H. & Kimura, J. Altered energy metabolism in Alzheimer\u2019s disease. J Neurol Sci. https:\/\/doi.org\/10.1016\/0022-510X(96)00033-0 (1996).","journal-title":"J Neurol Sci."},{"key":"30892_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2017\/5472792","volume":"2017","author":"JWD Griffin","year":"2017","unstructured":"Griffin, J. W. D. & Bradshaw, P. C. Amino acid catabolism in Alzheimer\u2019s disease brain: friend or foe?. Oxid Med Cell Longev. 2017, 5. https:\/\/doi.org\/10.1155\/2017\/5472792 (2017).","journal-title":"Oxid Med Cell Longev."},{"key":"30892_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16344","author":"F Yin","year":"2022","unstructured":"Yin, F. Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. https:\/\/doi.org\/10.1111\/febs.16344 (2022).","journal-title":"FEBS J."},{"key":"30892_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155807","author":"SK Pulukool","year":"2022","unstructured":"Pulukool, S. K. et al. Elevated ATP, cytokines and potential microglial inflammation distinguish exfoliation glaucoma from exfoliation syndrome. Cytokine https:\/\/doi.org\/10.1016\/j.cyto.2022.155807 (2022).","journal-title":"Cytokine"},{"issue":"12","key":"30892_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-022-03401-1","volume":"12","author":"RS Swaroop","year":"2022","unstructured":"Swaroop, R. S., Pradhan, S. S., Darshan, V. M. D., Phalguna, K. S. & Sivaramakrishnan, V. Integrated network pharmacology approach shows a potential role of Ginseng catechins and ginsenosides in modulating protein aggregation in\u00a0Amyotrophic\u00a0Lateral Sclerosis. 3 Biotech. 12(12), 1\u201319. https:\/\/doi.org\/10.1007\/s13205-022-03401-1 (2022).","journal-title":"3 Biotech."},{"key":"30892_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94607-5","author":"SKS Bhagavatham","year":"2021","unstructured":"Bhagavatham, S. K. S. et al. Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-021-94607-5 (2021).","journal-title":"Sci Rep."},{"issue":"3","key":"30892_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1152\/physiolgenomics.00208.2006","volume":"28","author":"WS Liang","year":"2007","unstructured":"Liang, W. S. et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics. 28(3), 311\u2013322. https:\/\/doi.org\/10.1152\/physiolgenomics.00208.2006 (2007).","journal-title":"Physiol Genomics."},{"issue":"9","key":"30892_CR53","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1093\/cercor\/bht101","volume":"24","author":"M Hokama","year":"2014","unstructured":"Hokama, M. et al. Altered expression of diabetes-related genes in Alzheimer\u2019s disease brains: the Hisayama study. Cereb Cortex. 24(9), 2476\u20132488. https:\/\/doi.org\/10.1093\/cercor\/bht101 (2014).","journal-title":"Cereb Cortex."},{"issue":"3","key":"30892_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell 153(3), 19\u201322. https:\/\/doi.org\/10.1016\/j.cell.2013.03.030 (2013).","journal-title":"Cell"},{"key":"30892_CR55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806883105","author":"NC Berchtold","year":"2008","unstructured":"Berchtold, N. C. et al. Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci USA https:\/\/doi.org\/10.1073\/pnas.0806883105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"30892_CR56","doi-asserted-by":"publisher","unstructured":"Nachun D, Ramos EM, Karydas A, et al. Systems-level analysis of peripheral blood gene expression in dementia patients reveals an innate immune response shared across multiple disorders. bioRxiv. 2019. doi:https:\/\/doi.org\/10.1101\/2019.12.13.875112","DOI":"10.1101\/2019.12.13.875112"},{"issue":"1","key":"30892_CR57","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44(1), W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucleic Acids Res."},{"key":"30892_CR58","doi-asserted-by":"publisher","unstructured":"Chen EY, Tan CM, Kou Y, et al. Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14. doi:https:\/\/doi.org\/10.1186\/1471-2105-14-128","DOI":"10.1186\/1471-2105-14-128"},{"issue":"W1","key":"30892_CR59","doi-asserted-by":"publisher","first-page":"W171","DOI":"10.1093\/nar\/gky458","volume":"46","author":"DJB Clarke","year":"2018","unstructured":"Clarke, D. J. B. et al. EXpression2Kinases (X2K) Web: Linking expression signatures to upstream cell signaling networks. Nucleic Acids Res. 46(W1), W171\u2013W179. https:\/\/doi.org\/10.1093\/nar\/gky458 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"30892_CR60","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai, B. et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron 105(6), 975\u2013991. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.015 (2020).","journal-title":"Neuron"},{"issue":"1","key":"30892_CR61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JAD-160913","volume":"56","author":"L Shen","year":"2017","unstructured":"Shen, L. et al. Proteomics analysis of blood serums from Alzheimer\u2019s disease patients using iTRAQ labeling technology. J Alzheimer\u2019s Dis. 56(1), 361\u2013378. https:\/\/doi.org\/10.3233\/JAD-160913 (2017).","journal-title":"J Alzheimer\u2019s Dis."},{"key":"30892_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz9360","author":"L Higginbotham","year":"2020","unstructured":"Higginbotham, L. et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aaz9360 (2020).","journal-title":"Sci Adv."},{"key":"30892_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002750","author":"B Martin","year":"2008","unstructured":"Martin, B. et al. iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer\u2019s mice: Understanding the interface between physiology and disease. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0002750 (2008).","journal-title":"PLoS ONE"},{"key":"30892_CR64","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-131823","author":"X Sui","year":"2014","unstructured":"Sui, X. et al. Proteomic analysis of serum proteins in triple transgenic Alzheimer\u2019s disease mice: Implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early alzheimer\u2019s disease. J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.3233\/JAD-131823 (2014).","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"W1","key":"30892_CR65","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49(W1), W388\u2013W396. https:\/\/doi.org\/10.1093\/nar\/gkab382 (2021).","journal-title":"Nucleic Acids Res."},{"key":"30892_CR66","unstructured":"Giuseppe Paglia, Matteo Stocchero and GA. Unbiased metabolomic investigation of Alzheimer\u2019s disease brain points to dysregulation of mitochondrial aspartate metabolism."},{"key":"30892_CR67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","volume":"107","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez, R., Garc\u00eda-Barrera, T. & G\u00f3mez-Ariza, J. L. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer\u2019s disease. J Pharm Biomed Anal. 107, 75\u201381. https:\/\/doi.org\/10.1016\/j.jpba.2014.10.010 (2015).","journal-title":"J Pharm Biomed Anal."},{"issue":"1","key":"30892_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-018-0119-x","volume":"6","author":"Y Nagata","year":"2018","unstructured":"Nagata, Y. et al. Comparative analysis of cerebrospinal fluid metabolites in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort. Biomark Res. 6(1), 1\u201311. https:\/\/doi.org\/10.1186\/s40364-018-0119-x (2018).","journal-title":"Biomark Res."},{"key":"30892_CR69","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","volume":"102","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez, R., Garc\u00eda-Barrera, T., Vitorica, J. & G\u00f3mez-Ariza, J. L. Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer\u2019s disease by direct infusion mass spectrometry. J Pharm Biomed Anal. 102, 425\u2013435. https:\/\/doi.org\/10.1016\/j.jpba.2014.10.009 (2015).","journal-title":"J Pharm Biomed Anal."},{"key":"30892_CR70","doi-asserted-by":"publisher","unstructured":"Bhatti AB, Usman M, Ali F, Satti SA. Vitamin supplementation as an adjuvant treatment for Alzheimer\u2019s disease. J Clin Diagnostic Res. 2016;10(8):OE07\u2013OE11. doi:https:\/\/doi.org\/10.7860\/JCDR\/2016\/20273.8261","DOI":"10.7860\/JCDR\/2016\/20273.8261"},{"key":"30892_CR71","doi-asserted-by":"publisher","unstructured":"Trushina E, Nemutlu E, Zhang S, et al. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer\u2019s disease. PLoS One. 2012;7(2). doi:https:\/\/doi.org\/10.1371\/journal.pone.0032737","DOI":"10.1371\/journal.pone.0032737"},{"key":"30892_CR72","doi-asserted-by":"crossref","unstructured":"Fagan AM, Head D, Shah AR, et al. Decreased CSF A\u03b242 correlates with brain atrophy in cognitively normal elderly. Ann Neurol. Published online 2009.","DOI":"10.1002\/ana.21559"},{"key":"30892_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2009.12.005","author":"JM Zhuo","year":"2010","unstructured":"Zhuo, J. M. & Pratic\u00f2, D. Acceleration of brain amyloidosis in an Alzheimer\u2019s disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp Gerontol. https:\/\/doi.org\/10.1016\/j.exger.2009.12.005 (2010).","journal-title":"Exp Gerontol."},{"key":"30892_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111556","author":"A Bayraktar","year":"2021","unstructured":"Bayraktar, A. et al. Revealing the molecular mechanisms of alzheimer\u2019s disease based on network analysis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222111556 (2021).","journal-title":"Int J Mol Sci."},{"issue":"11","key":"30892_CR75","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","volume":"8","author":"EJ Mufson","year":"2008","unstructured":"Mufson, E. J., Counts, S. E., Perez, S. E. & Ginsberg, S. D. Cholinergic system during the progression of Alzheimer\u2019s disease: therapeutic implications. Expert Rev Neurother. 8(11), 1703\u20131718. https:\/\/doi.org\/10.1586\/14737175.8.11.1703 (2008).","journal-title":"Expert Rev Neurother."},{"issue":"3","key":"30892_CR76","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.bbrc.2020.05.015","volume":"527","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. Cerebral deficiency of vitamin B5 (D-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer\u2019s disease. Biochem Biophys Res Commun. 527(3), 676\u2013681. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.015 (2020).","journal-title":"Biochem Biophys Res Commun."},{"key":"30892_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2018.02.007","author":"BD Paul","year":"2018","unstructured":"Paul, B. D., Sbodio, J. I. & Snyder, S. H. Cysteine metabolism in neuronal redox homeostasis. Trends Pharmacol Sci. https:\/\/doi.org\/10.1016\/j.tips.2018.02.007 (2018).","journal-title":"Trends Pharmacol Sci."},{"key":"30892_CR78","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-110284","author":"LL Torres","year":"2011","unstructured":"Torres, L. L. et al. Peripheral oxidative stress biomarkers in mild cognitive impairment and alzheimer\u2019s disease. J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.3233\/JAD-2011-110284 (2011).","journal-title":"J Alzheimer\u2019s Dis."},{"key":"30892_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4574276","author":"IM De Toda","year":"2019","unstructured":"De Toda, I. M., Vida, C., Miguel, L. S. S. & De La Fuente, M. Function, oxidative, and inflammatory stress parameters in immune cells as predictive markers of lifespan throughout aging. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2019\/4574276 (2019).","journal-title":"Oxid Med Cell Longev."},{"key":"30892_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00231","author":"J Arslan","year":"2020","unstructured":"Arslan, J., Jamshed, H. & Qureshi, H. Early detection and prevention of Alzheimer\u2019s disease: role of oxidative markers and natural antioxidants. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2020.00231 (2020).","journal-title":"Front Aging Neurosci."},{"key":"30892_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14525-4","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. FMN reduces Amyloid-\u03b2 toxicity in yeast by regulating redox status and cellular metabolism. Nat Commun. Published online https:\/\/doi.org\/10.1038\/s41467-020-14525-4 (2020).","journal-title":"Nat Commun. Published online"},{"key":"30892_CR82","doi-asserted-by":"publisher","unstructured":"Malouf R, Grimley-Evans J. Vitamin B6 for cognition. Cochrane Database Syst Rev. 2003;(4). doi:https:\/\/doi.org\/10.1002\/14651858.cd004393","DOI":"10.1002\/14651858.cd004393"},{"key":"30892_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-13668-3 (2020).","journal-title":"Nat Commun."},{"key":"30892_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50205-0","author":"MG Fleszar","year":"2019","unstructured":"Fleszar, M. G. et al. Targeted metabolomic analysis of nitric oxide\/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-50205-0 (2019).","journal-title":"Sci Rep."},{"key":"30892_CR85","doi-asserted-by":"publisher","DOI":"10.1042\/bj3360001","author":"G Wu","year":"1998","unstructured":"Wu, G. & Morris, S. M. Arginine metabolism: nitric oxide and beyond. Biochem J. https:\/\/doi.org\/10.1042\/bj3360001 (1998).","journal-title":"Biochem J."},{"key":"30892_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(97)00024-9","author":"KZ Shen","year":"1997","unstructured":"Shen, K. Z., Cox, B. A. & Johnson, S. W. L-arginine potentiates GABA-mediated synaptic transmission by a nitric oxide-independent mechanism in rat dopamine neurons. Neuroscience https:\/\/doi.org\/10.1016\/S0306-4522(97)00024-9 (1997).","journal-title":"Neuroscience"},{"key":"30892_CR87","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2022.2090441","author":"R Sai Swaroop","year":"2022","unstructured":"Sai Swaroop, R. et al. Integrated multi-omic data analysis and validation with yeast model show oxidative phosphorylation modulates protein aggregation in amyotrophic lateral sclerosis. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2022.2090441 (2022).","journal-title":"J Biomol Struct Dyn."},{"issue":"10","key":"30892_CR88","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1007\/s12035-022-02992-3","volume":"59","author":"M Pinto","year":"2022","unstructured":"Pinto, M. et al. Adult-onset deficiency of mitochondrial complex III in a mouse model of Alzheimer\u2019s disease decreases amyloid beta plaque formation. Mol Neurobiol. 59(10), 6552\u20136566. https:\/\/doi.org\/10.1007\/s12035-022-02992-3 (2022).","journal-title":"Mol Neurobiol."},{"key":"30892_CR89","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049492","author":"SS Pradhan","year":"2022","unstructured":"Pradhan, S. S. et al. Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.049492 (2022).","journal-title":"Dis Model Mech."},{"key":"30892_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.04.005","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2013.04.005 (2013).","journal-title":"Immunity"},{"key":"30892_CR91","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314037","author":"L Sun","year":"2020","unstructured":"Sun, L., Yang, X., Yuan, Z. & Wang, H. Metabolic reprogramming in immune response and tissue inflammation. Arterioscler Thromb Vasc Biol. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314037 (2020).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"30892_CR92","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120236","author":"K Ganeshan","year":"2014","unstructured":"Ganeshan, K. & Chawla, A. Metabolic regulation of immune responses. Annu Rev Immunol. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120236 (2014).","journal-title":"Annu Rev Immunol."},{"key":"30892_CR93","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2013","author":"DB Zorov","year":"2014","unstructured":"Zorov, D. B., Juhaszova, M. & Sollott, S. J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00026.2013 (2014).","journal-title":"Physiol Rev."},{"key":"30892_CR94","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311401","author":"SJ Forrester","year":"2018","unstructured":"Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q. & Griendling, K. K. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311401 (2018).","journal-title":"Circ Res."},{"key":"30892_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413384","author":"P Kowalczyk","year":"2021","unstructured":"Kowalczyk, P. et al. Mitochondrial oxidative stress: a causative factor and therapeutic target in many diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222413384 (2021).","journal-title":"Int J Mol Sci."},{"key":"30892_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00440","author":"AK Gebre","year":"2018","unstructured":"Gebre, A. K., Altaye, B. M., Atey, T. M., Tuem, K. B. & Berhe, D. F. Targeting Renin\u2013Angiotensin system against Alzheimer\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.00440 (2018).","journal-title":"Front Pharmacol."},{"key":"30892_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810139","author":"R Loera-Valencia","year":"2021","unstructured":"Loera-Valencia, R., Eroli, F., Garcia-Ptacek, S. & Maioli, S. Brain renin\u2013angiotensin system as novel and potential therapeutic target for Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms221810139 (2021).","journal-title":"Int J Mol Sci."},{"key":"30892_CR98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1914017117","author":"X Cai","year":"2020","unstructured":"Cai, X. et al. Imaging the effect of the circadian light\u2013dark cycle on the glymphatic system in awake rats. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.1914017117 (2020).","journal-title":"Proc Natl Acad Sci USA."},{"key":"30892_CR99","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1974-18.2019","author":"KN Mortensen","year":"2019","unstructured":"Mortensen, K. N. et al. Impaired glymphatic transport in spontaneously hypertensive rats. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.1974-18.2019 (2019).","journal-title":"J Neurosci."},{"key":"30892_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624538","author":"LH Fairley","year":"2021","unstructured":"Fairley, L. H., Wong, J. H. & Barron, A. M. Mitochondrial regulation of microglial immunometabolism in Alzheimer\u2019s disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.624538 (2021).","journal-title":"Front Immunol."},{"key":"30892_CR101","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-020-09860-4","author":"ME Conway","year":"2020","unstructured":"Conway, M. E. Alzheimer\u2019s disease: targeting the glutamatergic system. Biogerontology https:\/\/doi.org\/10.1007\/s10522-020-09860-4 (2020).","journal-title":"Biogerontology"},{"key":"30892_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207452","author":"VN Bukke","year":"2020","unstructured":"Bukke, V. N. et al. The dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: from pathophysiology to pharmacotherapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21207452 (2020).","journal-title":"Int J Mol Sci."},{"key":"30892_CR103","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2007-11113","author":"CP Jacob","year":"2007","unstructured":"Jacob, C. P. et al. Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.3233\/JAD-2007-11113 (2007).","journal-title":"J Alzheimer\u2019s Dis."},{"key":"30892_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00660","author":"Y Xu","year":"2020","unstructured":"Xu, Y., Zhao, M., Han, Y. & Zhang, H. GABAergic inhibitory interneuron deficits in Alzheimer\u2019s disease: implications for treatment. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00660 (2020).","journal-title":"Front Neurosci."},{"key":"30892_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00573","author":"M Druart","year":"2019","unstructured":"Druart, M. & Le Magueresse, C. Emerging roles of complement in psychiatric disorders. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2019.00573 (2019).","journal-title":"Front Psychiatry."},{"key":"30892_CR106","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62167","author":"TKY Lim","year":"2021","unstructured":"Lim, T. K. Y. & Ruthazer, E. S. Microglial trogocytosis and the complement system regulate axonal pruning in vivo. Elife https:\/\/doi.org\/10.7554\/eLife.62167 (2021).","journal-title":"Elife"},{"issue":"24","key":"30892_CR107","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijms222413647","volume":"22","author":"A Shah","year":"2021","unstructured":"Shah, A., Kishore, U. & Shastri, A. Complement system in Alzheimer\u2019s disease. Int J Mol Sci. 22(24), 5. https:\/\/doi.org\/10.3390\/ijms222413647 (2021).","journal-title":"Int J Mol Sci."},{"key":"30892_CR108","doi-asserted-by":"publisher","DOI":"10.2174\/157015909787602823","author":"B Uttara","year":"2009","unstructured":"Uttara, B., Singh, A., Zamboni, P. & Mahajan, R. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/157015909787602823 (2009).","journal-title":"Curr Neuropharmacol."},{"issue":"W1","key":"30892_CR109","doi-asserted-by":"publisher","first-page":"W367","DOI":"10.1093\/nar\/gkac364","volume":"50","author":"GP Hunt","year":"2022","unstructured":"Hunt, G. P. et al. GEOexplorer: a webserver for gene expression analysis and visualisation. Nucleic Acids Res. 50(W1), W367\u2013W374. https:\/\/doi.org\/10.1093\/nar\/gkac364 (2022).","journal-title":"Nucleic Acids Res."},{"key":"30892_CR110","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1092","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkw1092 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"30892_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-32205-3","volume":"13","author":"M Pilarczyk","year":"2022","unstructured":"Pilarczyk, M. et al. Connecting omics signatures and revealing biological mechanisms with iLINCS. Nat Commun. 13(1), 1\u201313. https:\/\/doi.org\/10.1038\/s41467-022-32205-3 (2022).","journal-title":"Nat Commun."},{"key":"30892_CR112","doi-asserted-by":"publisher","unstructured":"Pan X, Nasaruddin M Bin, Elliott CT, et al. Alzheimer\u2019s disease-like pathology has transient effects on the brain and blood metabolome. Neurobiol Aging. 2016;38:151\u2013163. doi:https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.11.014","DOI":"10.1016\/j.neurobiolaging.2015.11.014"},{"issue":"1","key":"30892_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-75197-0","volume":"10","author":"AA Naik","year":"2020","unstructured":"Naik, A. A. et al. Systems analysis of avascular necrosis of femoral head using integrative data analysis and literature mining delineates pathways associated with disease. Sci Rep. 10(1), 1\u201320. https:\/\/doi.org\/10.1038\/s41598-020-75197-0 (2020).","journal-title":"Sci Rep."},{"key":"30892_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/srep19633","author":"MP Scott-Boyer","year":"2016","unstructured":"Scott-Boyer, M. P. et al. A network analysis of cofactor-protein interactions for analyzing associations between human nutrition and diseases. Sci Rep. https:\/\/doi.org\/10.1038\/srep19633 (2016).","journal-title":"Sci Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30892-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30892-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30892-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T06:24:08Z","timestamp":1678083848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30892-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["30892"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-30892-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"20 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3695"}}